# TAKEDA PHARMACEUTICAL CO LTD

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/takeda-pharmaceutical-co-ltd |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 16 |
| Claims under review | 2 |
| Evidence records | 10 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-11-16T04:49:37.426467+00:00 |
| Last reviewed | 2026-11-16T04:49:37.426467+00:00 |

## Identity

- Legal name: TAKEDA PHARMACEUTICAL CO LTD
- Display name: TAKEDA PHARMACEUTICAL CO LTD

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-11-16T04:49:37.426467+00:00 |
| Completeness | 0.318 |
| Record Quality | 0.719 |
| Directors | 0 |
| Committees | 0 |
| Governance events | 0 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | NOT_REVIEWED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | PUBLISHED |
| events | INSUFFICIENT_EVIDENCE |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Executive leadership

- Andrew S. Plump: President of Research & Development and Representative Director [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:7
- Christophe Weber: President, CEO & Representative Director [CEO]. Status: unknown. claim_id=alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:8
- Gabriele Ricci: Chief Data & Technology Officer. Status: unknown. claim_id=alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:9
- Iwaaki Taniguchi: Senior Vice President of Corporate Finance & Controlling Department. Status: unknown. claim_id=alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:10
- Milano Furuta: CFO & Director [CFO]. Status: unknown. claim_id=alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:11
- Mwana Lugogo: Chief Ethics & Compliance Officer. Status: unknown. claim_id=alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:12
- Norimasa Takeda: Chief Accounting Officer & Corporate Controller [CAO]. Status: unknown. claim_id=alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:13

## Scoped resources

- `alpha://company/takeda-pharmaceutical-co-ltd` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record
- `alpha://company/takeda-pharmaceutical-co-ltd/identity` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=identity
- `alpha://company/takeda-pharmaceutical-co-ltd/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=corporate-structure
- `alpha://company/takeda-pharmaceutical-co-ltd/board` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=board
- `alpha://company/takeda-pharmaceutical-co-ltd/committees` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=committees
- `alpha://company/takeda-pharmaceutical-co-ltd/leadership` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=leadership
- `alpha://company/takeda-pharmaceutical-co-ltd/ownership` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=ownership
- `alpha://company/takeda-pharmaceutical-co-ltd/financials` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=financials
- `alpha://company/takeda-pharmaceutical-co-ltd/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=capital-structure
- `alpha://company/takeda-pharmaceutical-co-ltd/compensation` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=compensation
- `alpha://company/takeda-pharmaceutical-co-ltd/governance` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=governance
- `alpha://company/takeda-pharmaceutical-co-ltd/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=shareholder-governance
- `alpha://company/takeda-pharmaceutical-co-ltd/audit` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=audit
- `alpha://company/takeda-pharmaceutical-co-ltd/legal` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=legal
- `alpha://company/takeda-pharmaceutical-co-ltd/risk` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=risk
- `alpha://company/takeda-pharmaceutical-co-ltd/cyber` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=cyber
- `alpha://company/takeda-pharmaceutical-co-ltd/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=ai-governance
- `alpha://company/takeda-pharmaceutical-co-ltd/agents` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=agents
- `alpha://company/takeda-pharmaceutical-co-ltd/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=ecosystem
- `alpha://company/takeda-pharmaceutical-co-ltd/events` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=events
- `alpha://company/takeda-pharmaceutical-co-ltd/relationships` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=relationships
- `alpha://company/takeda-pharmaceutical-co-ltd/assessments` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=assessments
- `alpha://company/takeda-pharmaceutical-co-ltd/evidence` (contract): https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Andrew S. Plump: President of Research & Development and Representative Director. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5ba72a5428d5253813178005d729953b373ae659576c4688544dd96896f6f5fe.
- Christophe Weber: President, CEO & Representative Director. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7bcafb2a13b7a4f4d225d6f990e62aea997765d74e9d316284126511b4eb8d3c.
- Gabriele Ricci: Chief Data & Technology Officer. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:032ad08cfaf6677ae6bbdec6d09999af087a7232b2103714ef0fbdd67532e0cf.
- Iwaaki Taniguchi: Senior Vice President of Corporate Finance & Controlling Department. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4d75d88881aa3452d15e42ac5f5e70129a81b4a0cedeadd46721eaafebb5ca8f.
- Milano Furuta: CFO & Director. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0075f8b9affede8845d2b8d817feda25ab8af963875129c9c4b0b418dab40a54.
- Mwana Lugogo: Chief Ethics & Compliance Officer. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4a3ab2ce2264c27e9dd58ed26840129bfb82645016e03b406b7c2d24961bea67.
- Norimasa Takeda: Chief Accounting Officer & Corporate Controller. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5783bae66030e6c612df33383109164a6f2f88cb31effa784a9aa555290e6b5c.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- NOT_ASSERTED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- Nikkei 225 (N225). Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:index_membership:14. Valid from: 2026-09-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a85cb0f133ac79b34267f0170bb622469329c946ded083827300ea3dda974d34.
- TOPIX (TOPX). Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:index_membership:15. Valid from: 2026-07-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c88870a50b506c48841562cf15adb48d4f7f6b94b745dedc8e86b9428d9a44a9.

## Legal Name

- TAKEDA PHARMACEUTICAL CO LTD. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555.

## Entity Status

- Public listing published. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555.

## Published Fact

- US. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555.
- Healthcare. Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555.

## Security Listing

- TAK (NYSE). Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555.
- TKPHF (OTC). Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:security_listing:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555.
- 4502 (TSE). Claim: alpha:claim:company:0113f5b9-9c05-4862-b582-c28c0ac06e8b:security_listing:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | NOT_ASSERTED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:f5603a4a51750fdc77fbe5e07c24b697611b3820f794ea07c40d49976cbd9555: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd).
- alpha:projection-evidence:document:5ba72a5428d5253813178005d729953b373ae659576c4688544dd96896f6f5fe: [Takeda Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TAK).
- alpha:projection-evidence:document:7bcafb2a13b7a4f4d225d6f990e62aea997765d74e9d316284126511b4eb8d3c: [Takeda Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TAK).
- alpha:projection-evidence:document:032ad08cfaf6677ae6bbdec6d09999af087a7232b2103714ef0fbdd67532e0cf: [Takeda Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TAK).
- alpha:projection-evidence:document:4d75d88881aa3452d15e42ac5f5e70129a81b4a0cedeadd46721eaafebb5ca8f: [Takeda Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TAK).
- alpha:projection-evidence:document:0075f8b9affede8845d2b8d817feda25ab8af963875129c9c4b0b418dab40a54: [Takeda Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TAK).
- alpha:projection-evidence:document:4a3ab2ce2264c27e9dd58ed26840129bfb82645016e03b406b7c2d24961bea67: [Takeda Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TAK).
- alpha:projection-evidence:document:5783bae66030e6c612df33383109164a6f2f88cb31effa784a9aa555290e6b5c: [Takeda Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TAK).
- alpha:projection-evidence:a85cb0f133ac79b34267f0170bb622469329c946ded083827300ea3dda974d34: [Nikkei 225](https://indexes.nikkei.co.jp/en/nkave/index/component?idx=nk225).
- alpha:projection-evidence:c88870a50b506c48841562cf15adb48d4f7f6b94b745dedc8e86b9428d9a44a9: [TOPIX](https://www.jpx.co.jp/automation/english/markets/indices/topix/files/topixweight_e.csv).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/takeda-pharmaceutical-co-ltd)
- [Public Markdown](https://registry.alpha.ac/companies/takeda-pharmaceutical-co-ltd.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/takeda-pharmaceutical-co-ltd?format=jsonld)
- MCP resource: `alpha://companies/takeda-pharmaceutical-co-ltd` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-11-16T10:56:50.191966+00:00; recorded 2026-11-16T10:56:50.191966+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.